Viewing nowGlimeprex 4 mg (Gliclazide)
Glimepiride 4mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

MFDS item code 201801002 · Approved 2018.02.28 · Insurance code 647303320
Improves glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be used as a supplement to dietary therapy and exercise, or as monotherapy. Additionally, it may be combined with insulin if control with oral hypoglycemic agents alone is insufficient. When blood sugar control is inadequate with sulfonylureas or monotherapy with metformin, it can be co-administered with metformin to enhance efficacy. Thus, this medication effectively improves blood sugar control in patients.
The dosage should be adjusted individually for each patient. Swallow without chewing with at least 1/2 glass of water. This drug is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this drug needed may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering drug to this drug There is no precise dose-equivalence relationship between this drug and other oral blood glucose-lowering drugs. When switching from another oral blood glucose-lowering drug to this drug, it is advisable to follow the instructions given under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustments at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be taken into account. 4) Dose adjustment during treatment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. This drug is administered at 8 mg once daily with the first meal, while insulin is started at a low dose and increased at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, adding metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this drug is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. It should not be administered in cases of allergy to this drug or its ingredients, or to sulfonylureas. There is no experience with this medication in patients with severely impaired liver or kidney function, and it is recommended to switch to insulin therapy in such cases. It is safest for women who are pregnant, possibly pregnant, or breastfeeding to avoid this medication. In cases of severe infections, pre- and post-operative conditions, or severe trauma, insulin therapy may be required, thus this medication should be avoided. Caution is needed in cases of gastrointestinal disturbances like diarrhea or vomiting as this can lead to improper food absorption and increase the risk of hypoglycemia. This medication contains lactose and should not be used in patients with hereditary conditions of lactose intolerance or galactose intolerance. During initial treatment, the risk of hypoglycemia is high, necessitating careful monitoring of blood sugar fluctuations, especially in the elderly, patients with poor nutritional status or irregular eating habits, unbalanced physical activity and carbohydrate intake, alcohol consumers, and those with impaired liver or kidney function. This medication can cause hypoglycemia, with symptoms such as headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness; immediate ingestion of sugar is required if symptoms occur. During initial administration or dosage changes, temporary visual disturbances such as blurred vision or gastrointestinal symptoms may occur. Rarely, liver function abnormalities, blood disorders, or allergic reactions may occur; report any unusual symptoms to a physician immediately. Regular meals, exercise, and weight maintenance are essential while taking this medication, and blood sugar control should be monitored consistently. If hypoglycemia occurs, immediate consumption of sugar is necessary, and it is advisable to carry sugary beverages or snacks at all times. Co-administration with other medications could affect blood sugar control, so inform your doctor or pharmacist about other medications you are taking. In cases of pregnancy or breastfeeding, it is safer to switch to insulin therapy rather than use this medication. Safety and efficacy in individuals under 18 years have not been established, thus it is not used in children. Elderly patients may have reduced kidney function, so dosage adjustments should be carefully considered. In case of overdose, severe hypoglycemia may occur; seek emergency treatment immediately if symptoms are severe. This medication should be stored out of reach of children and kept in its original container.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air or moisture. It is best kept at room temperature, between 1 degree and 30 degrees Celsius, avoiding very hot or cold conditions.
Pale blue rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
HLB Pharmaceuticals Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.